Skip to main content

Advertisement

SpringerLink
Log in

Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Rummel MJ, Al-Batran SE, Kim SZ et al (2005) Bendamustine plus rituximab is effective and has favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma. J Clin Oncol 23:3383–3389

    Article  PubMed  CAS  Google Scholar 

  2. Robinson KS, Williams ME, van der Jagt RH et al (2008) Phase II multicenter study of bendamustine plus rituximab in patients with relapsed B-cell and mantle cell non-Hodgkin's lymphoma. J Clin Oncol 26:4473–4479

    Article  PubMed  CAS  Google Scholar 

  3. Rummel MJ, Niederle N, Maschmeyer G et al (2009) Bendamustine plus rituximab is superior in respect of progression free survival and CR rate when compared to CHOP plus rituximab as first-line treatment of patients with advanced follicular, indolent, and mantle cell lymphoma: final results of a randomized phase III study of the StiL (Study Group Indolent Lymphoma, Germany). Blood 114:168–169

    Google Scholar 

  4. Kahl BS, Bartlett NL, Leonard JP et al (2010) Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin's lymphoma: results from a multicenter study. Cancer 116:106–114

    PubMed  CAS  Google Scholar 

  5. Maung ZT, Wood AC, Jackson GH, Turner GE, Appleton AL, Hamilton PJ (1994) Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia. Br J Haematol 88:649–652

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Texas Oncology-Amarillo Cancer Center, Amarillo, TX, USA

    Seah H. Lim, Srinivas Pathapati, James Langevin & Andrew Hoot

  2. Hematologic Malignancy Program, Texas Oncology-Amarillo Cancer Center, 1000 Coulter Drive, Amarillo, TX, 79106, USA

    Seah H. Lim

Authors
  1. Seah H. Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Srinivas Pathapati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James Langevin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrew Hoot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seah H. Lim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lim, S.H., Pathapati, S., Langevin, J. et al. Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine. Ann Hematol 91, 643–644 (2012). https://doi.org/10.1007/s00277-011-1307-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-011-1307-z

Keywords

Search

Navigation